Clinical Trials Browser

Phase 1 × Has results × figitumumab × Clear all

NCT00729833 2014-06-09

Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors

Phase 1 Terminated

45 enrolled 18 charts

Other solid neoplasm

Advanced Cancer

NCT00474760 2013-12-17

Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors

Phase 1 Completed

65 enrolled 35 charts

Sarcoma, Ewing

NCT00976508 2013-12-13

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

Phase 1 Terminated

24 enrolled 10 charts

BreastGastrointestinalGenitourinarySarcomaThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT01653158 2013-10-30

CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies

Phase 1 Completed

46 enrolled 34 charts

Advanced Non-Hematologic Malignancies

NCT00603538 2013-04-11

Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer

Phase 1 Completed

19 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT00560573 2013-03-21

Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer

Phase 1 Completed

46 enrolled 21 charts

Carcinoma, Non-Small-Cell Lung

NCT01536145 2013-03-15

CP-751,871 Treatment For Patients With Multiple Myeloma

Phase 1 Completed

47 enrolled 12 charts

Multiple Myeloma